| Literature DB >> 35379610 |
Annie LeBlanc1,2, Marie Baron2, Patrick Blouin2, George Tarabulsy3,4, Francois Routhier5,6, Catherine Mercier5,6, Jean-Pierre Despres5,2, Marc Hébert5,7, Yves De Koninck5,7, Caroline Cellard4,7, Delphine Collin-Vézina3,8, Nancy Côté2,4, Émilie Dionne2, Richard Fleet5,9, Marie-Hélène Gagné3,10, Maripier Isabelle4,7, Lily Lessard9,11, Matthew Menear5,2, Chantal Merette5,7, Marie-Christine Ouellet4,6, Marc-André Roy5,7, Marie-Christine Saint-Jacques3,4, Claudia Savard7,12.
Abstract
INTRODUCTION: The COVID-19 pandemic and associated restrictive measures have caused important disruptions in economies and labour markets, changed the way we work and socialise, forced schools to close and healthcare and social services to reorganise. This unprecedented crisis forces individuals to make considerable efforts to adapt and will have psychological and social consequences, mainly on vulnerable individuals, that will remain once the pandemic is contained and will most likely exacerbate existing social and gender health inequalities. This crisis also puts a toll on the capacity of our healthcare and social services structures to provide timely and adequate care. The MAVIPAN (Ma vie et la pandémie/ My Life and the Pandemic) study aims to document how individuals, families, healthcare workers and health organisations are affected by the pandemic and how they adapt. METHODS AND ANALYSIS: MAVIPAN is a 5-year longitudinal prospective cohort study launched in April 2020 across the province of Quebec (Canada). Quantitative data will be collected through online questionnaires (4-6 times/year) according to the evolution of the pandemic. Qualitative data will be collected with individual and group interviews and will seek to deepen our understanding of coping strategies. Analysis will be conducted under a mixed-method umbrella, with both sequential and simultaneous analyses of quantitative and qualitative data. ETHICS AND DISSEMINATION: MAVIPAN aims to support the healthcare and social services system response by providing high-quality, real-time information needed to identify those who are most affected by the pandemic and by guiding public health authorities' decision making regarding intervention and resource allocation to mitigate these impacts. MAVIPAN was approved by the Ethics Committees of the Primary Care and Population Health Research Sector of CIUSSS de la Capitale-Nationale (Committee of record) and of the additional participating institutions. TRIAL REGISTRATION NUMBER: NCT04575571. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: COVID-19; mental health; public health
Mesh:
Year: 2022 PMID: 35379610 PMCID: PMC8980732 DOI: 10.1136/bmjopen-2021-048749
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Study design
Figure 2Summary of measures. MAVIPAN, Ma vie et la pandémie/My Life and the Pandemic.